Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 8/29/26 | Tenax Therapeutics (TENX) | Simdax for Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/28/26 | Cytokinetics (CYTK) | Myqorzo for Cardiomyopathy - Hypertrophic | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/26/26 | Agenus (AGEN) | AGEN2041 for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/26/26 | Agenus (AGEN) | balstilimab for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/20/26 | Nuvation Bio (NUVB) | safusidenib erbumine for Brain Cancer (Malignant Glioma; AA and glioblastoma) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/17/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 10/28/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 10/31/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |